Methylprednisolone for Coronavirus Disease 2019 (COVID-19): Was Benjamin Rush Prescient?

Affiliations

Editorial

Jeffrey L Lennox. Clin Infect Dis. 2021.

. 2021 May 4;72(9):e382-e383.

doi: 10.1093/cid/ciaa1262.

¹ Emory University, School of Medicine, Department of Medicine, Atlanta, Georgia, USA.

No abstract available

Keywords: COVID-19; SARS-CoV-2; corticosteroid; methylprednisolone; remdesivir.

Comment on

Methylprednisolone as Adjunctive Therapy for Patients Hospitalized With Coronavirus Disease 2019 (COVID-19; Metcovid): A Randomized, Double-blind, Phase IIb, Placebo-controlled Trial.
Jeronimo CMP, Farias MEL, Val FFA, Sampaio VS, Alexandre MAA, Melo GC, Safe IP, Borba MGS, Netto RLA, Maciel ABS, Neto JRS, Oliveira LB, Figueiredo EFG, Oliveira Dinelly KM, de Almeida Rodrigues MG, Brito M, Mourão MPG, Pivoto João GA, Hajjar LA, Bassat Q, Romero GAS, Naveca FG, Vasconcelos HL, de Araújo Tavares M, Brito-Sousa JD, Costa FTM, Nogueira ML, Baía-da-Silva DC, Xavier MS, Monteiro WM, Lacerda MVG; Metcovid Team. Jeronimo CMP, et al. Clin Infect Dis. 2021 May 4;72(9):e373-e381. doi: 10.1093/cid/ciaa1177. Clin Infect Dis. 2021. PMID: 32785710 Free PMC article. Clinical Trial.